Follow-up study of L059 (levetiracetam) in epileptic patients with partial onset seizures by open label method.

Next Previous
Trial Profile

Follow-up study of L059 (levetiracetam) in epileptic patients with partial onset seizures by open label method.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2015

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions
  • Sponsors UCB Pharma Inc

    • Most Recent Events

    • 15 Jan 2008 Status changed from in progress to completed.
    • 03 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top